◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › G › GUD

Knight Therapeutics Inc. (GUD) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-16

Knight Therapeutics Inc. (GUD) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Montreal, Canada with about 830 employees. Its market capitalization is roughly CAD 916 million. In the fiscal year ended 2025-12-31, GUD reported CAD 450M in revenue and (CAD 5M) in net income.

Knight Therapeutics Inc. focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Interactive charts & full statements →

GUD Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCAD 450MCAD 371MCAD 328MCAD 294M—
Gross ProfitCAD 200MCAD 174MCAD 153MCAD 138M—
Operating Income (EBIT)(CAD 2M)CAD 7MCAD 6M(CAD 17M)—
Net Income(CAD 5M)CAD 4M(CAD 17M)(CAD 30M)—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GUD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-06-302025-03-31
Total RevenueCAD 144MCAD 148MCAD 133MCAD 107MCAD 88M
Gross ProfitCAD 70MCAD 69MCAD 65MCAD 45MCAD 35M
Operating Income (EBIT)CAD 9MCAD 11MCAD 6M(CAD 4M)(CAD 6M)
Net Income(CAD 3M)CAD 13MCAD 9M(CAD 13M)CAD 2M

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GUD Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends PaidCAD 0MCAD 0MCAD 0MCAD 0M—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GUD Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-06-302025-03-312024-12-31
Dividends PaidCAD 0MCAD 0MCAD 0MCAD 0MCAD 0M—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GUD Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCAD 1.0BCAD 964MCAD 946MCAD 1.1B—
Total LiabilitiesCAD 279MCAD 169MCAD 199MCAD 229M—

CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GUD viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← GUACAll “G” companiesGUI →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.